Abbreviations: ECs, endothelial cells; eNOS, endothelial nitric oxide synthase; ETS, environmental tobacco smoke; LOD, low limit of detection. 
| INTRODUC TI ON
There is a well-established dose-response relation between tobacco consumption and low birthweight. [1] [2] [3] It has been suggested, but not verified, that women exposed to environmental tobacco smoke (ETS) during pregnancy also deliver infants smaller/shorter for gestational age. 2, [4] [5] [6] [7] Previous studies suggested that the restricted fetal growth in women who smoke is in part mediated by reduced blood flow in uterine and fetal vessels due to increased vascular resistance. [8] [9] [10] Nitric oxide is one factor that relaxes muscular tone in vessels, thereby reducing vascular resistance. Nitric oxide is produced by the intracellular endothelial enzyme endothelial nitric oxide synthase (eNOS). [8] [9] [10] The eNOS activity and concentration are reduced in endothelial cells (ECs) from the fetal umbilical vessels of women who smoke and are correlated with umbilical serum cotinine concentration and birthweight. [8] [9] [10] Most studies have investigated ETS based on self-reporting, which carries a risk of bias, but smoking status can be quantified objectively by measuring cotinine, the relatively stable oxidative degradation product of nicotine, in hair, urine or blood. 11 Nicotine has a serum t½ of ≈90 minutes, whereas cotinine has a longer t½ of ≈6-30 hours. It is possible to detect limited ETS exposure using sensitive mass spectrometry methods with a low limit of detection (LOD) for cotinine. 12 In accordance with previous studies, in this study, we defined cotinine levels below .2 ng/mL as nonsmoking, those between .2 and 14.9 ng/mL as ETS, and those above 14.9 ng/mL as smoking.
12
To the best of our knowledge, eNOS has not been investigated previously in the umbilical vein of infants born to women exposed to ETS. We hypothesize that there is a dose-response relation between maternal ETS exposure (as evidenced by serum cotinine levels measured by mass spectrometry), eNOS activity/concentration, and birthweight. it? (N/a little/Y much).The inclusion process has been described in detail previously, 9 and is illustrated in the flow diagram ( Figure 1 ).
| MATERIAL AND ME THODS

| Study participants
| Quantification of cotinine
Cotinine concentrations were measured in serum samples from 263 fetal umbilical veins. Samples were mixed with isotopically labeled internal standards and analyzed using a hybrid triple quadrupole linear ion-trap mass spectrometer (LC/MS/MS; UFLCXR, Shimadzu Corporation, Kyoto, Japan; QTRAP 5500; Sciex, Framingham, MA, USA). The coefficient of variation was 26% at the LOD = 0.2 ng/mL) and 9% at LOD = 30 ng/mL. The method has been described in detail previously. 12 
| Quantification of eNOS activity and concentration
The eNOS activity in the samples was quantified by duplicate determination of the conversion of 14 C-l-arginine to 14 C-l-citrulline with a few modifications of previously described methods. 8, 9 In brief, ECs were scraped from the surface of umbilical veins and stored at −80°C.
For the analysis, the number of cells in the samples was determined by duplicate cell counting before the samples were homogenized using repeat freeze-thaw cycles. The homogenate was diluted in buffer containing 14 C-l-arginine, calcium, and the cofactors calmodulin, tetrahydrobiopterin, flavin adenine dinucleotide, and β-nicotinamide adenine dinucleotide phosphate (reduced form) and was incubated for 30 minutes at 37°C. 14 C-l-citrulline was isolated by column chromatography and quantified by liquid scintillation counting. Finally, eNOS activity was calculated based on the mean formation of 14 C-l-citrulline per minute and the mean concentration of ECs in the sample.
Key Message
Limited amounts of environmental tobacco exposure during pregnancy do not have an immediate consequence for infant weight, length, or umbilical endothelial nitric oxide synthase.
The eNOS concentration in the samples was quantified using the human eNOS Quantikine Immunoassay Kit (R&D Systems, Abingdon, UK) with minor modifications, as described previously.
9
Recombinant human eNOS standards were used for internal quality assurance. The analytical within-series coefficient of variation was 3-5%, and the between-series coefficient of variation was 2-5% for concentrations ranging from .1 to 3.8 ng/mL.
The eNOS activity and concentration were measured in umbilical and chorionic arteries and veins, but no differences could be observed; accordingly, only umbilical vein levels are presented.
| Statistical analyses
Descriptive data are presented as the mean ± SD, 95% confidence 
| Ethical approval
The investigation conforms to the principles outlined in the 
| RE SULTS
| Study participants
In the study cohort, 175 women had serum cotinine levels below the LOD of .2 ng/mL and were grouped according to a previous classification 12 as nonsmokers; 50 had cotinine levels between .2 and 14.9 ng/mL and were classified as exposed to ETS; and 38 had cotinine levels above 14.9 ng/mL and were classified as smokers. All women characterized as nonsmokers or exposed to ETS reported themselves as nonsmokers or former smokers, or reported to have stopped smoking early in the pregnancy. All women but one classified as smokers reported themselves as a smoker; the one woman reported to be an ex-smoker who had smoked more than 20 cigarettes a day prior to pregnancy but had ceased smoking at gestational week 12. Her cotinine level at delivery was 15.2 ng/mL, just above the cutoff level for active smoking.
The women in the three groups did not differ significantly in age, body mass index, years of education, parity, Apgar score at 5 minutes, or umbilical arterial pH at birth (Table 1) . However, smokers were more likely to be unemployed (33 vs. 6% among nonsmokers and women exposed to ETS) and to be single (5 vs. 0% among nonsmokers and women exposed to ETS). Additionally, smokers were more likely to deliver by elective cesarean section (28.9 vs.16.9%, P = .07) than were either nonsmokers or women exposed to ETS, and gave birth to significantly smaller/shorter infants with regard to weight, length, and head circumference (P < .003). Infants born to women exposed to ETS were 47 ± 70 g larger than infants born to nonsmoking women, but this difference was not significant (P = .48).
The difference between the infants in these two groups in length was .1 cm (P = .85) and the difference in head circumference 1 cm (P = .38) (Figure 2 ).
| Cotinine
The cotinine concentration was (quartiles) .06/.09/.12 ng/mL in infants born to nonsmokers, .27/.37/.81 ng/mL in infants born to women exposed to ETS, and 43.0/63.8/108.1 ng/mL in infants born to smokers. The serum cotinine concentration in the umbilical vein was significantly higher in infants born to smokers than in infants born to nonsmokers (P = .001) or women exposed to ETS (P = .001).
When evaluating the effect of nicotine on fetal growth as judged by cotinine levels, we observed a borderline correlation (P = .067) between cotinine concentration and birthweight for the entire population (R 2 = .07) (Figure 3 ). This correlation was weaker in infants born to nonsmokers and women exposed to ETS but was stronger in infants born to smokers. No correlation between birthweight and cotinine concentration was seen in infants born to women exposed to ETS (R 2 = 0.02). Similar results were obtained for infants born to nonsmoking women, as well as for birth length and head circumference (data not shown).
| eNOS activity and concentration
The eNOS activity in the umbilical vein of maternal smokers a Nonsmokers were defined as having a cotinine level below .2 ng/mL, environmental smokers as having a cotinine level between .2 and 14.9 ng/mL, and smokers as having a cotinine level above 14.9 ng/mL. Asterisk indicates a significant difference when compared with nonsmokers (P < .05). Q1 = first quartile; Q3 = third quartile.
TA B L E 1 Characteristics of the participants
activity and concentration in infants born to women exposed to ETS (R 2 = .70, P = .06). However, there was no correlation between serum cotinine concentration and eNOS activity or concentration in infants born to women exposed to ETS (data not shown). There was no improvement when specific eNOS activity (activity per unit mass) was calculated. A tendency toward a positive correlation between birthweight and eNOS activity (R 2 = .04, P = .23) and eNOS concentration (R 2 = .02, P = .47) was observed in infants born to smokers (Figure 4) . A weak and nonsignificant correlation was found between birthweight and eNOS activity (R 2 = .24, P = .29) and eNOS concentration (R 2 = .07, P = .07) among infants born to women exposed to ETS. No correlation between eNOS activity or concentration, and infant length or head circumference was observed in infants born to nonsmokers or women exposed to ETS. Interestingly, the eNOS activity level was significantly lower (P = .003) in women who delivered vaginally, primarily driven by the elective cesarean group, in which the number of both acute cesarean and vaginal deliveries was significantly higher (P < .001). 2011 Canadian retrospective study that included more than 10 000 exposed and nonexposed pregnant women with self-reported smoking habits showed a lower birthweight by 54 g, a smaller head circumference by .24 cm, and a shorter length by .29 cm in the exposed group than in the nonexposed group. However, the exposed women were younger, heavier, had fewer years of education, and were more likely to be unemployed compared with the women in the present study. 13 Taken together, these studies suggest that infants born to women exposed to ETS are significantly smaller than infants born to nonsmoking women.
| D ISCUSS I ON
Cotinine concentrations in smokers are directly related to the amount of smoking. 6 In the current study, 50 women were characterized as exposed to ETS based on a serum cotinine concentration between .2 and 14.9 ng/mL; of these, only four had a serum concentration above 1.0 ng/mL. There is no consensus in the literature regarding the correct cutoffs for cotinine to indicate nonsmoking, ETS, and active smoking; however, some studies suggest <3.0 ng/mL for low exposure to ETS and >12 ng/mL for high exposure to ETS. 11, 14, 15 These data would indicate that the majority of women in the current study who were characterized as environmental smokers were exposed to a very limited amount of ETS. Infants born to smokers are approximately 300 g smaller than infants born to nonsmokers, 9 and there is a well-established dose-response correlation between the number of cigarettes smoked and birthweight. 2 A trend toward a doseresponse relation was reported in pregnant Chinese women exposed to ETS, but it was not significant. 16 Previous publications have suggested a threshold effect for the correlation between environmental smoking indicated by serum cotinine level and birthweight. 17 Our data support a dose-response relation, but the limited number of women with a serum cotinine concentration above .2 ng/mL, and therefore an assumed significant exposure to ETS, made it impossible to establish this relation in this group (Figure 3) .
In smoking individuals, it has been suggested that nicotine acts directly on the endothelium, causing vasoconstriction by inhibiting eNOS. [8] [9] [10] This reduction in eNOS is seen not only in the uterine small arteries of women who smoke but also in the umbilical vein of infants born to smokers, and is significantly related to both the number of cigarettes smoked and birthweight. [8] [9] [10] Exposure to tobacco smoke has deleterious effects on endothelial function that are partially reversible after the exposure has ceased. 18 A previous study
showed that eNOS concentration and activity in the fetal umbilical vein were positively associated with infant weight among nonsmokers, suggesting that eNOS concentartion and activity is important.
9
To the best of our knowledge, the current study is the first to investigate serum cotinine and eNOS in infants born to.
The present findings support the association of eNOS in the umbilical veins with birthweight, but not with serum cotinine concentration, in infants born to mothers exposed to ETS. As previously published, eNOS concentration and activity are related to birthweight and cotinine concentration in infants born to smokers. 9 The gestational age at birth was slightly lower in smokers than in both nonsmokers and ETS (Table 1 ). This could have had an impact on the measured eNOS concentration and activity in the fetal umbilical vein; however, no correlation could be observed between eNOS and gestational age in any of the groups (data not shown). The lack of an association between eNOS and cotinine concentration in infants born to women exposed to ETS in the current study might be explained by the low levels of cotinine measured, and by the limited number of women assumed to be exposed to significant levels of ETS. Thus, we cannot exclude the possibility that maternal ETS exposure is associated with lower eNOS Nonsmokers were defined as having a cotinine level below .2 ng/mL, environmental smokers as having a cotinine level between .2 and 14.9 ng/mL, and smokers as having a cotinine level above 14.9 ng/ mL. Difference displayed as mean with 95% confidence interval. Asterisk indicates a significant difference between groups (P < .05).
TA B L E 2 Relation between smoking status and size at birth activity and birthweight (Table 2) . Furthermore, the effects of maternal exposure to tobacco smoke might extend further into childhood.
2,19,20
The strengths of our study are the ethnic homogeneity of the participants and the sensitive method using a low LOD for determining serum cotinine level, thereby enabling an objective detection of very low levels of tobacco exposure. In addition, the effect of low nicotine exposure, as seen in ETS, is supported by the umbilical cord measurement of eNOS activity and concentration.
The limitations of our study include the small number of observations of intermediate serum cotinine levels. Most women in the ETS group had very low levels of cotinine, indicating limited exposure. One possible explanation is that these women avoided ETS during the final weeks prior to delivery. Furthermore, cotinine metabolizes relatively rapidly. Cotinine kinetics and metabolism depend on CYP2A6 variants, and the half-life of cotinine ranges from 6 to 30 hours, which is considerably longer than the ≈90-minute half-life of nicotine. [21] [22] [23] These data indicate that the cotinine level measured at delivery covers ETS exposure at least during the 3-6 days prior to delivery. The deliveries took an average of 12.6 hours (range 0-23.5), during which time the women were unlikely to be exposed to nicotine; thus, the measured cotinine level is a minimum value. ETS exposure could have been measured over a longer period of time if the cotinine level in hair had been determined, assuming an average hair growth of 1 cm per month.
24
The women might have been exposed to nicotine earlier in their pregnancy, but most fetal growth occurs toward the end of pregnancy;
thus, any growth retardation due to ETS is most likely to be observed late in pregnancy. The present study cannot conclude that an intermediate level of ETS exposure affects fetal growth. At best, low-level ETS exposure seems to have a negligible effect on fetal growth.
| CON CLUS ION
Our study suggests that infants born to ETS, as judged by umbilical serum cotinine levels close to .2 ng/mL, are not associated with lower birthweight or reduced eNOS activity and concentration in the fetal vascular bed. However, based on the literature and current data, we cannot exclude the possibility of associations between birthweight, eNOS activity/concentration, and cotinine concentration in the umbilical vein of infants born to women with substantially higher ETS exposure.
